Page last updated: 2024-08-26

sr141716 and hemopressin

sr141716 has been researched along with hemopressin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castro, LM; Dale, CS; de Souza, LL; Devi, LA; Ferro, ES; Giorgi, R; Gomes, I; Gupta, A; Heimann, AS; Luchessi, AD; Pagano, RL; Rioli, V1
Bánki, L; Deli, MA; Dvorácskó, S; Horváth, G; Kékesi, G; Keresztes, A; Macedonio, G; Mollica, A; Pieretti, S; Stefanucci, A; Tömböly, C; Tuboly, G; Walter, FR; Zádor, F1
Dodd, GT; Luckman, SM; Lutz, B; Mancini, G1
Maccallini, C; Macedonio, G; Mirzaie, S; Mollica, A; Novellino, E; Stefanucci, A1

Reviews

1 review(s) available for sr141716 and hemopressin

ArticleYear
Hemopressin Peptides as Modulators of the Endocannabinoid System and their Potential Applications as Therapeutic Tools.
    Protein and peptide letters, 2016, Volume: 23, Issue:12

    Topics: Analgesics; Animals; Cannabinoids; Endocannabinoids; Hemoglobins; Hypotension; Peptide Fragments; Piperidines; Protein Binding; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid, mu; Rimonabant

2016

Other Studies

3 other study(ies) available for sr141716 and hemopressin

ArticleYear
Hemopressin is an inverse agonist of CB1 cannabinoid receptors.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Cell Line; Drug Inverse Agonism; Hemoglobins; Humans; Ligands; Peptide Fragments; Receptor, Cannabinoid, CB1

2007
Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors.
    European journal of medicinal chemistry, 2019, Sep-15, Volume: 178

    Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Enkephalins; Indoles; Mice; Molecular Structure; Naphthalenes; Oxycodone; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid, mu; Structure-Activity Relationship

2019
The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, May-26, Volume: 30, Issue:21

    Topics: Analysis of Variance; Animals; Behavior, Animal; Benzoxazines; Chlorocebus aethiops; Circadian Rhythm; COS Cells; Cyclohexanols; Dose-Response Relationship, Drug; Drinking Behavior; Dronabinol; Drug Administration Routes; Eating; Food Deprivation; Green Fluorescent Proteins; Hemoglobins; Hyperphagia; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Naphthalenes; Peptide Fragments; Piperidines; Protein Transport; Psychotropic Drugs; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Time Factors; Transfection

2010